Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
0 hedge funds and large institutions have $0 invested in Minerva Surgical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 13 closing their positions.
100% less funds holding
Funds holding: 13 → 0 (-13)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $6.04M → $0 (-$6.04M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 13
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$5.66M |
| 2 |
VVM
Versant Venture Management
San Francisco,
California
|
-$275K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$34.5K |
| 4 |
State Street
Boston,
Massachusetts
|
-$26.6K |
| 5 |
FRA
Frank Rimerman Advisors
Palo Alto,
California
|
-$18.3K |
UTRS Hedge Fund Activity: Q4 2023 in Review
0 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q4 2023, worth a combined $0 — down 100% from $6.04M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of UTRS and 0 opened new positions — a net loss of 13 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was NEA Management Company, exiting entirely with an estimated $5.66M sold.
- 0 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q4 2023, down from 13 in Q3 2023.
- Funds reported $0 of Minerva Surgical, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Minerva Surgical, Inc. Common Stock positions in Q4 2023 and 13 closed out, a net change of -13 holders.
- The largest Minerva Surgical, Inc. Common Stock seller in Q4 2023 was NEA Management Company, an estimated $5.66M sold.
Based on aggregated 13F filings for Q4 2023.